MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/jcm14217801

Медицинская библиотека · Journal of clinical medicine · 2025

Upadacitinib's Effectiveness and Safety as a Second- or Third-Line Therapy in Patients with Ulcerative Colitis: Data from a Real-World Study.

Mocci Giammarco, Tursi Antonio, Scaldaferri Franco, Napolitano Daniele, Pugliese Daniela, Maconi Giovanni, Cataletti Giovanni, Pica Roberta, Cassieri Claudio, Savarino Edoardo Vincenzo, De Barba Caterina, Costa Francesco, Ceccarelli Linda, Marzo Manuela, Elisei Walter, Monterubbianesi Rita, Faggiani Roberto, Lombardi Giovanni, Patturelli Marta, Ribaldone Davide Giuseppe, Bertani Lorenzo, Rodinò Stefano, Sebkova Ladislava, Bodini Giorgia, Pasta Andrea, Pranzo Giuseppe, Serio Mariaelena, Scarcelli Antonella, Luppino Ileana, Ferronato Antonio, Spagnuolo Rocco, Luzza Francesco, Gravina Antonietta Gerarda, Pellegrino Raffaele, Vespere Giuliana, Sedda Silvia, D'Onofrio Vittorio, De Luca Leonardo, Allegretta Leonardo, Cazzato Alessia Immacolata, Fanigliuolo Libera, Grossi Laurino, Cortellini Fabio, Forti Giacomo, Tonti Paolo, Neve Viviana, Piergallini Simona, Di Fonzo Michela, Iacopini Federico, Capone Pietro, Gaiani Federica, Kayali Stefano, Mucherino Caterina, D'Antonio Elvira, Montesano Laura, Cocco Andrea, D'Ascoli Berardino, Colucci Raffaele, Bachetti Francesco, Orrù Giorgia, Onidi Francesca Maria, Usai Satta Paolo, Picchio Marcello, Papa Alfredo

СтатьяПеревод пока не подготовлен

Аннотация

Background

Upadacitinib (UPA), a selective anti-JAK1 agent, obtained refundability from the Italian National Health System in July 2023 for its use in patients with ulcerative colitis (UC) refractory to other therapies, including anti-TNF-α, anti-integrins, and ustekinumab. At present, no Italian data are available about its effectiveness and safety in the real world.

Methods

A retrospective assessment of clinical and endoscopic activity was performed according to the Mayo score. The primary endpoints were to evaluate the effectiveness and safety of UPA.

Results

We included 202 consecutive UC patients (M/F 119/83, median age 42). The clinical remission and clinical response rates were 45.5% (92/202) and 63.5% (128/202), respectively, at 8 weeks and 60.2% and 81.7%, respectively, at the end of the follow-up. Clinical remission was achieved more frequently when UPA was used as a first-line rather than a second-/third-line treatment (p = 0.609). Mucosal healing was reported in 84.6% of patients at the median follow-up time. Adverse events occurred in six patients (2.5%), whereas four patients (2%) underwent colectomy.

Conclusions

This large real-world study shows that UPA is an effective and safe treatment for UC patients.

Для цитирования: Mocci Giammarco, Tursi Antonio, Scaldaferri Franco, Napolitano Daniele, Pugliese Daniela, Maconi Giovanni, Cataletti Giovanni, Pica Roberta, Cassieri Claudio, Savarino Edoardo Vincenzo, De Barba Caterina, Costa Francesco, Ceccarelli Linda, Marzo Manuela, Elisei Walter, Monterubbianesi Rita, Faggiani Roberto, Lombardi Giovanni, Patturelli Marta, Ribaldone Davide Giuseppe, Bertani Lorenzo, Rodinò Stefano, Sebkova Ladislava, Bodini Giorgia, Pasta Andrea, Pranzo Giuseppe, Serio Mariaelena, Scarcelli Antonella, Luppino Ileana, Ferronato Antonio, Spagnuolo Rocco, Luzza Francesco, Gravina Antonietta Gerarda, Pellegrino Raffaele, Vespere Giuliana, Sedda Silvia, D'Onofrio Vittorio, De Luca Leonardo, Allegretta Leonardo, Cazzato Alessia Immacolata, Fanigliuolo Libera, Grossi Laurino, Cortellini Fabio, Forti Giacomo, Tonti Paolo, Neve Viviana, Piergallini Simona, Di Fonzo Michela, Iacopini Federico, Capone Pietro, Gaiani Federica, Kayali Stefano, Mucherino Caterina, D'Antonio Elvira, Montesano Laura, Cocco Andrea, D'Ascoli Berardino, Colucci Raffaele, Bachetti Francesco, Orrù Giorgia, Onidi Francesca Maria, Usai Satta Paolo, Picchio Marcello, Papa Alfredo. Upadacitinib's Effectiveness and Safety as a Second- or Third-Line Therapy in Patients with Ulcerative Colitis: Data from a Real-World Study.. Journal of clinical medicine. 2025. DOI: 10.3390/jcm14217801.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.